Euan S. Thomson, PhD., Global President Ophthalmic Devices and Head of Digital Business Unit for Carl Zeiss Meditec, and Medical Advisor to Advanced Oncotherapy plc, shares his views on the future of data sharing for proton therapy and for Advanced Oncotherapy plc in particular.
Treatment planning for proton therapy is complex and requires a number of steps to achieve the desired dose distributions. Without a national or international strategy to coordinate unified treatment protocols, patients treated with protons have been managed with several delivery modalities, treatment paradigms and fractionation schemes. A key area for optimising the treatment planning process is therefore in gaining experience by encouraging all centres to share treatment plans with each other, retrospectively and in real time. To facilitate this process, Advanced Oncotherapy is working on treatment planning software to be hosted on the cloud.
[To read more]